GTx Inc.

(GTXI) Trade

By |

Profile

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.

Contact Information

Website: www.gtxinc.com
Email: investor.relations@gtxinc.com
Main Phone: +1 901 523-9700
Address: 175 Toyota Plaza
Address 2: 7th Floor
State: TN
City / Town: Memphis
Country: USA
Postal Code: 38103

Issuer Information

Exchange: NSC
CEO: Marc S. Hanover
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 14.87 $ -0.05 (-0.34%)
Last Price 14.87 Change $ -0.05 Change % -0.34 Tick N/A
Bid 10.05 Bid Size 100.00 Ask 15.87 Ask Size 200.00
Open 15.05 High 15.28 Low 14.30 Prev Close 14.92
Last Trade Volume 67,913 52 Wk Hi 23.40 52 Wk Low 5.10
Market Cap 357.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 24,031,191.00 EPS (TTM) -1.98 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 23
Number of Buys 3 14
Number of Sells 0 9
Net Activity 2374 1799234
Last 10 Buys Shares
Robert J. Wills 1,000
J. Kenneth Glass 1,000
Marc S. Hanover 1,000
Marc S. Hanover 1,000
Marc S. Hanover 1,000
Marc S. Hanover 1,000
Marc S. Hanover 1,000
J. Kenneth Glass 1,000
J. Kenneth Glass 1,000
J. Kenneth Glass 1,000
Last 10 Sell Shares
Henry P. Doggrell 1,000
Henry P. Doggrell 1,000
Marc S. Hanover 1,000
Jason T. Shackelford 1,000
Jason T. Shackelford 1,000
Marc S. Hanover 1,000
James T. Dalton 1,000
Mark E. Mosteller 1,000
Mark E. Mosteller 1,000
James T. Dalton 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 45 45 45 45
Low Target Price Estimate 30 30 30 30
Mean Target Price Estimate 37.5 37.5 37.5 37.5
Standard Deviation 10.61 10.61 10.61 10.61
Date of Most Recent Estimate 05/29/18 05/29/18 05/20/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1